Markman Advisors
Hedge fund analyst, investment advisor, patents/litigation, tech

Crossroads: A Veteran Patent Stock About To Finally Come Of Age?

Certain avant-garde works of art, wine and even people can sometimes take years to come into their own. The same can be true of inventions, and likewise, patents. That time may have finally arrived for Crossroads Systems, Inc. ("Crossroads") (NASDAQ:CRDS). After pursuing scores of patent litigations going back more than a decade, which have resulted in numerous settlements, but only modest revenue, the sudden widespread commercialization of Crossroads' inventions may have finally matured to a point that will open the doors to significant, share-price-shifting patent-licensing revenue. Crossroads' decade-old patent-monetization campaign may be about to come of age.

At Markman Advisors, we are seasoned patent litigation attorneys who are all registered patent-attorneys with the United States Patent and Trademark...

Join Seeking Alpha PRO to read this archived article and 11,574 other archived articles
IDEA GENERATORXExclusive access to 10 PRO ideas every day
INVESTING IDEAS LIBRARYXExclusive access to PRO library of more than 15,000 ideas
SECTOR EXPERT NETWORKXExclusive access to all sector experts for direct consultation
PERFORMANCE TRACKINGXTrack performance of all PRO stock ideas
PROFESSIONAL TOOLSXProfessional Idea Filters to zero-in based on industry, market cap and more
"In just the first month of using PRO, I used it to generate two ideas which were actionable for me. As a result of these two positions, I have earned more than 20 times the annual subscription costs for PRO."Michael Yagemann, Greenbridge Capital
"I am pleasantly surprised with the scope of small and mid-cap coverage PRO offers. You can't find that any where else."Patrick Rice, Mainstay Capital Management
You may cancel at any time for any reason, and receive a prompt refund for membership on months paid and not used (max. 6 months). Details